Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction

Autor: Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau

Publikováno v: ESC Heart Failure, Vol 10, Iss 1, Pp 442-452 (2023)

Abstract Aims Left ventricular ejection fraction (LVEF) ≤ 40% is a well‐established risk factor for mortality after acute coronary syndromes (ACS). However, the long‐term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41–49%

Externí odkaz: https://doaj.org/article/0ea3352bcc7a46c587f6b45e5a04c0c6

Long‐term mortality after acute coronary syndromes among patients with normal, mildly reduced, or reduced ejection fraction

Autor: Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau

Publikováno v: ESC Heart Failure. 10:442-452

Left ventricular ejection fraction (LVEF) ≤ 40% is a well-established risk factor for mortality after acute coronary syndromes (ACS). However, the long-term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41-49%) after ACS remains

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddff673e64c54351c78ef34fc5af3d1
https://doi.org/10.1002/ehf2.14201

Platelet Reactivity and Coagulation Markers in Patients with COVID-19

Autor: Rinaldo Focaccia Siciliano, Adriadne Justi Bertolin, Felipe G. Lima, Ludhmila Abrahão Hajjar, Roberto R. Giraldez, Rocio Salsoso, Jose C. Nicolau, Alexandra Vieira, Talia Dalcoquio, Cyrillo Cavalheiro-Filho, Remo H.M. Furtado, Esper G. Kallas, Luciano Moreira Baracioli, Celia Maria Cassaro Strunz, Robert P. Giugliano, Roberto Kalil-Filho, Paul A. Gurbel, Udaya S. Tantry

Publikováno v: Advances in Therapy

Introdution COVID-19 is associated with an increased risk of thrombotic events. However, the contribution of platelet reactivity (PR) to the aetiology of the increased thrombotic risk associated with COVID-19 remains unclear. Our aim was to evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d07e328ce66a99f7f9b5261d387f17
http://europepmc.org/articles/PMC8176448

Associação entre Terapia com Estatinas e Menor Incidência de Hiperglicemia em Pacientes Internados com Síndromes Coronarianas Agudas

Autor: Andre Franci, Talia Dalcoquio, Paulo Genestreti, Remo H.M. Furtado, Luciano Moreira Baracioli, Cesar A. C. Pereira, Rocio Salsoso, Felipe G. Lima, Roberto R. Giraldez, Viviane Lima, Lucas C. Godoy, Jose C. Nicolau, Carlos A.K. Nakashima, Fernando Menezes, Aline Ferrari

Publikováno v: Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.116 n.2 2021
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Vol 116, Iss 2, Pp 285-294 (2021)
Arquivos Brasileiros de Cardiologia, Volume: 116, Issue: 2, Pages: 285-294, Published: 01 MAR 2021

Resumo Fundamento O maior risco de se desenvolver diabetes com o uso de estatinas é um desafio para a segurança do uso dessa classe de medicamentos em longo prazo. No entanto, poucos estudos analisaram essa questão durante síndromes coronarianas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2876a99ae2a5afaf8651521ea3a772e
http://europepmc.org/articles/PMC7909967

Patients with COVID ‐19 who experience a myocardial infarction have complex coronary morphology and high in‐hospital mortality: Primary results of a nationwide angiographic study

Autor: Adriano Caixeta, Daniela Calderaro, Carlos M. Campos, Renata do Val, Cristiano Guedes Bezerra, Patrícia O. Guimarães, Fabio Sandoli de Brito, Francis R. de Souza, Roberto Kalil Filho, Alexandre Abizaid, Ludhmila Abrahão Hajjar, Fernanda Mangione, Jose de Ribamar Costa, Felipe G. Lima, Breno de Alencar Araripe Falcão, Bruno Caramelli, Henrique Barbosa Ribeiro, Ricardo Cavalcante, Pedro A. Lemos, Leandro A Côrtes, Roxana Mehran, Natassja Huemer

Publikováno v: Catheterization and Cardiovascular Interventions

Objectives We aimed to explore angiographic patterns and in‐hospital outcomes of patients with concomitant coronavirus disease‐19 (COVID‐19) and myocardial infarction (MI). Background Patients with COVID‐19 may experience MI during the course

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4561c714d0860feb9ed2a979b5b6e7bb
https://doi.org/10.1002/ccd.29709